Skip to main content
. 2021 Nov 4;51(6):3001–3007. doi: 10.3906/sag-2007-87

Table 2.

PBE, pulmonary function tests and diffusing capacity results according to stage of disease.

Stage 1 (n = 26) Stage 2 (n = 45) Stage 3 (n = 8) Stage 4 (n = 5) p value*
PBE Mean ± SD 280.76 232.66 215.00 370.00 0.286
± 216.20 ± 151.63 ± 117.22 ± 216.79
FEV1/ FVC Mean ± SD 79.1154 75.0667 81.2500 77.4000 0.272
± 5.92 ± 7.67 ± 3.88 ± 10.13
FEV1 (mL/sn) Mean ± SD 2778.15 2270.44 2273.75 1866.00 0.013
± 878.70 ± 619.36 ± 882.20 ± 216.17
FEV1 (%) Mean ± SD 101.80 90.55 92.12 87.00 0.041
± 12.65 ± 18.88 ± 30.44 ± 18.34
FVC (mL) Mean ± SD 1860.00 1540.00 1890.00 1720.00 0.147
± 6160.00 ± 5450.00 ± 4400.00 ± 2960.00
FVC (%) Mean ± SD 108.38 102.00 94.50 98.80 0.182
± 13.83 ± 17.73 ± 28.13 ± 22.92
DLCO (%) Mean ± SD 96.6538 87.9556 85.8750 56.6000 0.00
± 16.62 ± 16.77 ± 28.07 ± 10.16

PBE: Peripheral blood eosinophilia, SD: Standard deviation, FEV1: Forced expiratory volume in the 1st second, FVC: Forced vital capacity, DLCO: Diffusing capacity,

*

One-way ANOVA.